CSL Limited
CSL
Classement en actions
#364
CSL Limited operates as a global biopharmaceutical company, engaged in the... CSL Limited operates as a global biopharmaceutical company, engaged in the research, development, manufacturing, marketing, and distribution of diverse pharmaceutical and allied products. Its extensive international footprint includes key markets such as Australia, the United States, Germany, the United Kingdom, Switzerland, and China. The company is structured into two principal operating segments: CSL Behring and CSL Seqirus. CSL Behring focuses on plasma-derived therapies, encompassing both plasma products and recombinant treatments. This segment also conducts significant research into both plasma and non-plasma therapeutics and derives revenue from intellectual property licensing and royalties. In contrast, CSL Seqirus is dedicated to the manufacturing and worldwide distribution of non-plasma biotherapeutic products, alongside developing a range of influenza-related solutions. Founded in 1916, CSL Limited maintains its corporate headquarters in Parkville, Australia.
Prix de l'action
$138.38
Capitalisation boursière
$66.41B
Changement (1 jour)
-0.18%
Changement (1 an)
-3.27%
Pays
AU
Échange CSL Limited (CSL)
Catégorie
Healthcare
Historique des divisions d’actions pour CSL Limited (CSL)
L’action CSL Limited (symbole : CSL) a subi un total de 1 divisions.
La division la plus récente a eu lieu le Oct 18, 2007.
Une action CSL achetée avant le Oct 18, 2007 équivaudrait aujourd’hui à 3 actions CSL.
La division la plus récente a eu lieu le Oct 18, 2007.
Une action CSL achetée avant le Oct 18, 2007 équivaudrait aujourd’hui à 3 actions CSL.
Liste des divisions d’actions
| Année | Division | Multiplicateur | Multiplicateur cumulatif |
|---|---|---|---|
| 2007-10-18 | 3:1 | x3 | x3 |
Divisions d’actions d’entreprises similaires ou concurrentes
| Entreprise | Nombre de divisions d’actions | Multiplicateur cumulatif | Pays |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
|
| 1 | x100 |
BE
|
